UC HEALTH LINE: Electroconvulsive Therapy Effective, but Often Misunderstood
CINCINNATIIn its depictions in popular culture, electroconvulsive therapy (ECT) evokes images of cruelty, as in the 1975 film "One Flew Over the Cuckoos Nest, or cartoonish comedy, with characters shown hooked up to an elaborate device with their hair standing on end.
Thats unfortunate, a UC Health psychiatrist says, because ECT is vastly different from such depictions and has helped numerous patients cope with psychiatric disorders such as depression and mania. Used correctly and with proper follow-up, it offers the potential for improved quality of life.
"Its the best mood stabilizer that we know of, says James Curell, MD, an associate professor in the University of Cincinnati (UC) Department of Psychiatry and Behavioral Neuroscience who administers ECT at UC Health University Hospital. (ECT is also available at the Lindner Center of HOPE, a mental health clinic and UC Health affiliate in Mason, Ohio.)
Curell says ECTs negative image goes back to the 1940s and 1950s, when there werent many treatments available for depression or bipolar disorder. "It was really overused, and in some cases even abused, he says.
Later, in "One Flew Over the Cuckoos Nest, the main charactera patient at a mental institutionis subjected to ECT as a means of controlling him. Hes also incorrectly depicted as fully conscious during the procedurewhich, incidentally, does not produce the desired effect.
"ECT was portrayed as a punishment rather than a therapeutic procedure, says Curell. "But the data on it has always been that its the most effective treatment for severe depression.
According to the National Institutes of Health, scientists are unsure of the exact mechanism of ECT. However, it appears to produce changes in the chemistry and functioning of the brain that act to reset the regulation of the patients mood. Studies have shown that it increases chemicals such as dopamine which play an important role in mood regulation.
Because its technically a surgical procedure and involves the use of anesthesia, ECT carries risks and is therefore not the first course of treatment for depression, Curell says.
A patient will usually be placed on antidepressants or a combination of medication and psychotherapy, but ECT is usually the next course of treatment if there is no improvement in mood.
Curell, who has 20 years of experience administering ECT, performs it on an outpatient basis at UC Health University Hospital. Its a three- to four-week course of treatment, three times a week. Patients are given a short-acting anesthetic and are asleep for the procedure, and are also given a muscle relaxer to keep them from having contractions.
Electrodes are placed on the head and an electric current is passed through the brain, producing a seizure that lasts about a minute. The entire procedure lasts about five to 10 minutes, and the patient spends time in a recovery room until he or she is fully alert.
Risks associated with ECT, in addition to any risks associated with anesthesia, include headache, upset stomach, muscle aches, memory loss and short-term confusion. Because heart rate and blood pressure increase during ECT, there is a risk of heart attack or stroke.
With successful ECT treatment, the patient continues to make progress in mood stabilization with the help of proper medication and psychotherapy. Research shows that there is about a 50 percent chance of relapse into depression if a proper course of treatment is not followed after ECT.
"ECT alone isnt enough, cautions Curell. "You also need to get adequate follow-up treatment.
Tags
Related Stories
UC names Suzanne Judd, PhD, as inaugural director of new Center for Public Health
April 2, 2026
Following an extensive national search, the University of Cincinnati College of Medicine has appointed Suzanne E. Judd, PhD, as the inaugural director of its newly established Center for Public Health. Judd, a renowned epidemiologist and interdisciplinary scholar, will lead the center’s mission to transform community health through innovative research, education and strategic advocacy.
Could GLP-1s help curb the opioid crisis?
April 1, 2026
The University of Cincinnati's John Winhusen was featured in a Rolling Stone article discussing the potential for GLP-1s to treat substance abuse disorders.
A legacy that leads: Honoring a beloved physician through the future of clinical medicine
March 31, 2026
After Cohen’s passing in 2023, the Harvey D. and Janet G. Cohen Charitable Foundation was established. With the establishment of the foundation, the Cohen trustees searched for a way to create lasting impact in Janet Cohen’s hometown while recognizing the compassion and dedication of her dear friend, Dr. Rouan.